🇺🇸 FDA
Patent

US 10851072

Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same

granted A61PA61P35/00

Quick answer

US patent 10851072 (Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00